Cargando…

Severe odynophagia in a patient developing after azithromycin intake: a case report

INTRODUCTION: Drug-induced esophageal ulcers most commonly cause heartburn, midsternal pain and dysphagia. In our clinic azithromycin is a relative widely used antibiotic for respiratory tract infections and otitis media because of its activity against Haemophilus influenzae and atypical pathogens,...

Descripción completa

Detalles Bibliográficos
Autores principales: Akyuz, Umit, Erzin, Yusuf, Yalniz, Fevzi Firat, Senkal, Ibrahim Volkan, Ekici, Isin Dogan, Pata, Cengiz
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2825200/
https://www.ncbi.nlm.nih.gov/pubmed/20205827
http://dx.doi.org/10.1186/1757-1626-3-48
_version_ 1782177792024117248
author Akyuz, Umit
Erzin, Yusuf
Yalniz, Fevzi Firat
Senkal, Ibrahim Volkan
Ekici, Isin Dogan
Pata, Cengiz
author_facet Akyuz, Umit
Erzin, Yusuf
Yalniz, Fevzi Firat
Senkal, Ibrahim Volkan
Ekici, Isin Dogan
Pata, Cengiz
author_sort Akyuz, Umit
collection PubMed
description INTRODUCTION: Drug-induced esophageal ulcers most commonly cause heartburn, midsternal pain and dysphagia. In our clinic azithromycin is a relative widely used antibiotic for respiratory tract infections and otitis media because of its activity against Haemophilus influenzae and atypical pathogens, and its ease of administration. After a thorough search in Pubmed the present case is the first one to report azithromycin-induced esophageal ulcer and associated symptoms in the literature. CASE PRESENTATION: A 61-year-old Caucasian man was admitted to our endoscopy unit for the investigation of odynophagia and retrosternal pain of new onset. His past medical history was unremarkable but had used azithromycin 500 mg/d for three days in the previous week. An upper endoscopy revealed an extensive serpiginous midesophageal ulcer in the presence of a normal squamocolumnar junction and biopsies from the edges and center of the lesion disclosed no neoplasia or infectious causes but a dense acute inflammatory infiltrate. The patient was put on a liquid diet, sucralfate proton pump inhibitor treatment and was symptom-free within two weeks. After four weeks on therapy a repeated upper endoscopic control examination demonstrated normal findings. CONCLUSION: To our knowledge this is the first such a case of azithromycin -induced esophageal ulceration. We think that a little time taken by the physician to warn the patients for taking every oral drug with sufficient amount of water might prevent this kind of complications.
format Text
id pubmed-2825200
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28252002010-02-20 Severe odynophagia in a patient developing after azithromycin intake: a case report Akyuz, Umit Erzin, Yusuf Yalniz, Fevzi Firat Senkal, Ibrahim Volkan Ekici, Isin Dogan Pata, Cengiz Cases J Case Report INTRODUCTION: Drug-induced esophageal ulcers most commonly cause heartburn, midsternal pain and dysphagia. In our clinic azithromycin is a relative widely used antibiotic for respiratory tract infections and otitis media because of its activity against Haemophilus influenzae and atypical pathogens, and its ease of administration. After a thorough search in Pubmed the present case is the first one to report azithromycin-induced esophageal ulcer and associated symptoms in the literature. CASE PRESENTATION: A 61-year-old Caucasian man was admitted to our endoscopy unit for the investigation of odynophagia and retrosternal pain of new onset. His past medical history was unremarkable but had used azithromycin 500 mg/d for three days in the previous week. An upper endoscopy revealed an extensive serpiginous midesophageal ulcer in the presence of a normal squamocolumnar junction and biopsies from the edges and center of the lesion disclosed no neoplasia or infectious causes but a dense acute inflammatory infiltrate. The patient was put on a liquid diet, sucralfate proton pump inhibitor treatment and was symptom-free within two weeks. After four weeks on therapy a repeated upper endoscopic control examination demonstrated normal findings. CONCLUSION: To our knowledge this is the first such a case of azithromycin -induced esophageal ulceration. We think that a little time taken by the physician to warn the patients for taking every oral drug with sufficient amount of water might prevent this kind of complications. BioMed Central 2010-02-03 /pmc/articles/PMC2825200/ /pubmed/20205827 http://dx.doi.org/10.1186/1757-1626-3-48 Text en Copyright ©2010 Akyuz et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Akyuz, Umit
Erzin, Yusuf
Yalniz, Fevzi Firat
Senkal, Ibrahim Volkan
Ekici, Isin Dogan
Pata, Cengiz
Severe odynophagia in a patient developing after azithromycin intake: a case report
title Severe odynophagia in a patient developing after azithromycin intake: a case report
title_full Severe odynophagia in a patient developing after azithromycin intake: a case report
title_fullStr Severe odynophagia in a patient developing after azithromycin intake: a case report
title_full_unstemmed Severe odynophagia in a patient developing after azithromycin intake: a case report
title_short Severe odynophagia in a patient developing after azithromycin intake: a case report
title_sort severe odynophagia in a patient developing after azithromycin intake: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2825200/
https://www.ncbi.nlm.nih.gov/pubmed/20205827
http://dx.doi.org/10.1186/1757-1626-3-48
work_keys_str_mv AT akyuzumit severeodynophagiainapatientdevelopingafterazithromycinintakeacasereport
AT erzinyusuf severeodynophagiainapatientdevelopingafterazithromycinintakeacasereport
AT yalnizfevzifirat severeodynophagiainapatientdevelopingafterazithromycinintakeacasereport
AT senkalibrahimvolkan severeodynophagiainapatientdevelopingafterazithromycinintakeacasereport
AT ekiciisindogan severeodynophagiainapatientdevelopingafterazithromycinintakeacasereport
AT patacengiz severeodynophagiainapatientdevelopingafterazithromycinintakeacasereport